2024: Top content and our year in review
2024 marked an exciting transition period for BioTechniques, following our acquisition by Taylor & Francis (Oxford, UK) at the end of 2023. We have been working to make the most of the vast swathe of journals that this acquisition brought us access to and are excited to see the fruits of these efforts begin to come through with new features in 2025. However, as we looked to the future and new features, we continued to publish all the content you know and love. Here is our round up of the top content published on site from 2024. Top editorial content...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
